and synthetic rhodopsin/GPCR chimeras 5 (optoXRs; Fig. 1b) , may help in illuminating both the normal circuit function and major disease mechanisms [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Here we illustrate the critical steps we have developed for the implementation of this optogenetic 6, 7 approach to probe the function of deep brain circuit elements in mammals. We first review the basic optogenetic control tools we have described, followed by discussion of optimization of expression, targeting and readout technology. We then present the necessary materials and outline a detailed series of our experimental protocols for integrating optogenetic neuronal manipulation with in vivo and ex vivo readout methods, including electrophysiological and optical measures.
Experimental design considerations
Temporally precise genetically encoded control. Classical neuronal manipulation techniques (electrical, pharmacological and genetic) either simultaneously affect surrounding cells and processes in addition to the target population or have slow kinetics and poor reversibility, thereby severely limiting the strength of conclusions that can be drawn. To overcome these spatial and temporal limitations, microbial and chimeric-vertebrate opsin genes ( Table 1) have been developed recently to control highly-defined electrical (Fig. 1a) and biochemical (Fig. 1b) activity with celltype selectivity, high temporal precision and rapid reversibility. As most neurons in the brain are not naturally light-sensitive, selective expression of opsin genes in targeted neural populations makes it possible to specifically control the activity in these populations, and the resulting fast on-off kinetics make it possible to evoke or inhibit neural activity within milliseconds, on a timescale relevant to the physiological brain functions.
At present, light-activated cation channels from two distinct algal species, channelrhodopsin-2 from Chlamydomonas reinhardtii (ChR2) 1, 2, 20 and channelrhodopsin-1 from Volvox carteri (VChR1) 3 ( Fig. 1a , left and middle), have proven to be a powerful pair of tools for controlling neural activity. ChR2 is maximally activated by blue light at 470 nm, whereas VChR1 remains significantly light sensitive even at 589 nm, a wavelength at which (importantly) ChR2 is no longer responsive (Fig. 1c) . Both ChR2 (deactivation time constant ~12 ms) and VChR1 (deactivation time constant ~120 ms) are able to transduce trains of millisecond-duration light flashes into defined spike trains up to 30-50 Hz 1, 2, 8 . Conversely, the chloride-pumping halorhodopsin from Natronomonas pharaonis (NpHR) has been shown to hyperpolarize neurons upon illumination with yellow light (Fig. 1c) . Because of sufficient spectral separation, NpHR and ChR2 can simultaneously be expressed in the same neurons to enable bidirectional optical control of neural activity. Moreover, both use all-trans retinal as the chromophore, which is abundantly present in mammalian brain tissue, and therefore these optogenetic tools are fully functional without the addition of chemical cofactors in vivo 4 .
Optimizing expression and function. For all of these proteins, expression issues will determine crucial aspects of performance. For example, because of the inactivation kinetics of ChR2, higher-expressing cells will be able to follow fast spike frequencies for longer periods of time, as these cells will be able to employ larger pools of the remaining non-inactivated ChR2. As another example, without the proper targeting sequences, high levels of microbial protein expression in mammalian cells can result in the aggregation of misfolded proteins in the Golgi, the endoplasmic reticulum and other intracellular compartments. As the conductance of individual rhodopsins is relatively low Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures (picosiemens or less for ChR2, and even lower for NpHR as a pump, due to its 1:1 coupling between photon absorption and ion flux), it is critical to maximize the number of molecules that are properly integrated into the cytoplasmic membrane, in addition to optimizing transcription of the opsin genes. For this reason, we have been constructing enhanced versions of halorhodopsin (eNpHR) by optimizing membrane trafficking sequences to increase the efficiency of membrane targeting 21, 22 . eNpHR exhibits higher levels of membrane expression and more robust photocurrents, and similar modifications could be applied to optimize other microbial light-activated proteins for enhanced photocurrents.
Molecular engineering is also leading to expanded and refined function of these microbial proteins by altering spectral properties, conductance or kinetics. One point mutation (H134R in ChR2 (ref. 23) ) has been shown to result in 2-3× enhanced cellular photocurrents 24 (but at the expense of slowed deactivation). Channelrhodopsin deactivation can be slowed so much that a novel utility is achieved; several C128 point mutants of ChR2 exhibit profound bistability, converting a brief pulse of light into a stable step in membrane potential 25 . Transduced cells are (at steady state) responsive to light at >100× lower light levels because of delayed exit of these proteins from the open state 25 . These C128 mutants are still activated by blue (470 nm) light, but photocurrents elicited by the opening of ChR2(C128A) and ChR2(C128S) can effectively be terminated by a pulse of green (542 nm) light. These engineered step function opsins (SFO) can optically sensitize cells to native patterns of input, by providing a sustained step depolarization of the target cell membrane potential that can increase excitability. In many settings this approach will be preferable to simply driving user-defined trains with possibly inappropriate spike times.
Related experimental leverage in terms of more natural control of native spike timing may also result from use of the optoXRs ( Fig. 1;  Table 1 ), which achieve temporally precise modulation of intracellular biochemical activity rather than direct control of spiking; of course, in some settings direct control of spike timing is the desired effect, in which case ChR2 or VChR1 are employed.
Genetic strategies for targeting expression to specific neural populations. Opsin genes can be selectively expressed in defined subsets of neurons in the brain using a variety of expression targeting strategies [26] [27] [28] . Here we focus on those techniques that have been shown to be effective in achieving functional expression of optogenic proteins in vivo.
Viral expression systems: unlike many other genetic targeting strategies requiring the use of transgenic animal models, viral vectors 29 based on lentivirus and adeno-associated virus (AAV) can be used to target opsin gene expression in a wide range of experimental subjects ranging from rodents to primates. Specifically, high titer lentivirus and AAV-based vectors (>10 9 transducing units (TU) ml − 1 for lentivirus and >10 12 genome copies (gc) ml − 1 for AAV vectors) can be easily produced in Biosafety Level 2-certified tissueculture facilities in 1-2 weeks, or alternatively obtained through a number of virus production facilities (e.g., Viral Vector Core, University of North Carolina, Chapel Hill, North Carolina, USA, and Virapur, LLC., San Diego, California, USA). These transduction methods have been shown to achieve high levels of functional opsin gene expression in neurons for several months.
Although most common AAV (Fig. 1d, top) and lentivirus (Fig. 1d, middle) type-specificity, allowing selective targeting in animals where transgenic technology is not accessible. In addition, viruses are capable of mediating high levels of opsin gene expression by introducing multiple gene copies into each target cell, an important function for overcoming the low transcriptional activity of some cell-specific promoters. In general for rodent brains, opsin gene expression reaches functional levels within 3 weeks after AAV injection and within 2 weeks after lentivirus injection. We have found that to reach the high steady-state levels of expression in distal axonal processes, longer periods of expression (>6 weeks) may be necessary.
Electroporation: specific cell types can also be targeted developmentally with in utero electroporation 24, 30 , e.g. at precisely timed embryonic days in mouse to target cortical layers II and III (E15.5), layer IV (E13.5) or layers V and VI (E12.5). In utero electroporation also can be used to express opsin genes in the inhibitory neurons of the striatum or in the hippocampus 30, 31 . In addition, unlike viral delivery methods, in utero electroporation can be used to deliver DNA of any size, therefore permitting the use of larger promoter segments to achieve higher cell-type specificity ( Table 2) . Electroporation also allows high copy number of genes to be introduced into the target cells. [65] [66] [67] 77 , zebrafish 68 , chicken 69 , mouse 8, 9, 11, 12, 14, 15, 32, 49 , rat 49 , primate 70 Step function opsin (SFO) genes: ChR2 4, 22 In vivo: C. elegans (requires supplementation of ATR) 4 and mouse 21, 22 opto-α 1 22, 32, 33 . Conditional expression systems: although cell-specific promoters are effective at restricting gene expression to subsets of genetically defined neurons, some promoters have weak transcriptional activity. Therefore when used to direct the expression of microbial opsin genes, many cell-specific promoters are unable to achieve the level of opsin gene expression necessary to mediate effective action potential firing or blockade. To amplify the transcriptional activity in a cellspecific manner, conditional AAV vectors [34] [35] [36] (Fig. 1d, bottom) have been developed recently to capitalize on the numerous cell-specific Cre-driver transgenic mouse lines that have been made available by individual labs and collective projects such as GENSAT. These conditional AAV expression vectors carry transgene cassettes that are activated only in the presence of Cre, and the use of strong ubiquitous promoters to drive the Cre-activated transgene selectively amplifies opsin gene expression level only in the cells of interest.
Circuit-specific cell targeting based on neuronal projection patterns: neurons identified by a given genetic marker can still be quite diverse, either receiving innervations from or sending axonal projections to distinct brain regions. For example, some of the tyrosine hydroxylase-expressing dopaminergic (DA) neurons in the midbrain innervate reward-related brain structures such as the nucleus accumbens, whereas other DA neurons project to motor control centers such as the striatum, and spatial separation between different DA neuron populations is not complete. However, as rhodopsins are trafficked to cellular processes including axons, the axonal processes may become light sensitive. Therefore, it may be possible to selectively control a connection-defined neural pathway through focal injection of viral vectors followed by photostimulation of axon terminals in the target downstream brain structure. For example, to study the medial prefrontal cortical afferents in the amygdala, it is possible to inject a viral vector carrying ChR2-enhanced yellow fluorescent protein (EYFP) into the medial prefrontal cortex and implant the stimulation optical fiber into the amygdala. It is even possible to combinatorially interrogate the role of multiple subsets of afferent fiber bundles using multiple optogenetic proteins with distinct spectral sensitivities (e.g., using yellow light to activate VChR1-expressing afferents independent of ChR2-expressing afferents within the same neural tissue).
A number of plant and microbial proteins and several viral vectors with unique anterograde-or retrograde-transporting properties 28, 37, 38 may be engineered with recombinases to activate gene expression in sub-populations of neurons with cell type-and circuit specificity. For example, expression of fusion proteins containing Cre and either wheat germ agglutinin or tetanus toxin fragment C in the cell bodies of one brain region will allow the recombinase to be trans-neuronally delivered to up-or down-stream neurons in another brain region. Similarly, viral vectors 39, 40 , such as rabies virus 28 or herpes simplex virus 1 (HSV-1) vectors, can be used for retrograde gene delivery, and the H129 strain 76 of HSV might be developed for anterograde gene delivery. When combined with conditional expression systems, either Cre-dependent transgenic mice or viral vectors, this strategy may allow circuit-specific gene expression in a variety of mammalian animal models not limited to mice. Moreover, microbial protein expression can also be restricted to specific intracellular compartments and locations by fusing to targeting motifs and protein domains 24, 41 . Readouts compatible with optogenetic control of intact circuits. Several classes of circuit readout can be made compatible with optogenetic control. First, voltage-sensitive dye (VSD) imaging is an effective approach for monitoring the electrical activity of large populations of neurons ex vivo and in vivo with high temporal resolution. VSDs are lipophilic molecules whose optical absorbance or emission properties vary depending on the electrical potential across the membrane 42 . Along with high-speed cameras to capture changes in the optical signal, VSD imaging allows researchers to measure electrical activity changes in neurons on the millisecond timescale and with micro-scale spatial resolution [43] [44] [45] [46] . Previously, we have utilized VSDs to image ex vivo and quantify the activity of neural circuits involved in depression-related behaviors 47 . VSD imaging can also be combined with optogenetic techniques to conduct all-optical stimulation and imaging of evoked circuit responses in brain slices. Optically compatible VSDs such as RH-155 (absorption ~700 nm) are sufficiently separated from the excitation peaks of ChR2, VChR1 and NpHR 48 ( Fig. 1c) to permit multimodal all-optical stimulation and imaging. The protocol described below for fast all-optical interrogation has been optimized for brain slices from Thy1ChR2-YFP transgenic mice 32, 33 . A second class of readout involves in vivo control integrated with either or both of electrical recording and behavioral measures. Targeting light-stimulation and electrical-recording devices to reach the site of opsin gene delivery poses an experimental challenge that can readily be overcome with the appropriate protocol. We have developed a fiber optic-based optical neural interface (ONI) that meets this challenge 49 . The ONI uses stereotactically implanted ( Fig. 2a-i ) cannula guides for targeted virus infusion and light delivery into desired brain structures (Fig. 3a) .
Stereotactic targeting of brain structures: stereotactic surgeries can be used to target opsin gene expression to genetically defined and spatially restricted neuronal populations in the brain and can also be used to place a light delivery device to target the transduced cells using widely available brain atlas coordinates 50 as described below. There are two major methods for stereotactically delivering lentiviral or AAV vectors to the brain. In the first approach, primarily applicable for in vitro acute slice electrophysiology or imaging studies, the viral vectors can be injected through a glass needle, targeted to the brain region of interest via a stereotactic frame; the use of fine glass needles fabricated from glass capillaries minimizes the extent of tissue damage. A small diameter Hamilton syringe can also be used in place of the glass needle; the Hamilton syringe can be mounted onto a micro-pump such as the WPI UltraMicroPump III, which is directly attached to a stereotactic frame.
The second approach utilizes a stereotactically implanted cannula guide not only to deliver virus but also to direct an optical fiber to the same brain area of interest (Fig. 3a) . In this approach, the use of a single cannula guide for both viral vector delivery and optical fiber targeting ensures the co-registration of transduced brain area and light illumination. The use of cannula guides and infusion cannulae is a well-suited method for infusion of compounds into specific brain areas. Cannula systems consist of three major components: cannula guide, injection (or internal) cannula and dummy cannula. The projection length of each component can be customized for each component depending on the brain region of interest. Depending on the experimental application, the material composition and physical dimensions of each component can also be varied; e.g., silica instead of steel cannulae are more suitable for integration with magnetic resonance imaging, and larger diameter cannula guides can be used with bigger rodents such as rats to accommodate the insertion of a larger diameter optical fiber to increase the volume of illumination. The cannula guide is chronically implanted onto the skull of each experimental subject (Fig. 2h) . A dummy cannula (stylet and screw cap) is temporarily inserted into the cannula guide between experiments to prevent clogging and infection. During behavioral experiments, an optical fiber can be inserted through the cannula guide to illuminate the light-sensitive neurons. In addition, bilateral cannula systems are suitable for targeting multiple brain regions within the same experimental subject.
Choice of light sources: there are several factors to be considered, including the intensity of light needed to reliably activate a sufficient volume of tissue and the ability to deliver high frequencies of light flashes to the experimental sample. For in vivo setups, it is also important to consider the mechanics and co-registration of the light delivery with the opsin-expressing brain region. For in vitro experiments where the tissue sample is manipulated under a microscope, most conventional light sources such as halogen/xenon arc lamps, LEDs and lasers can be directly coupled to the microscope's A dental drill is used to create a small craniotomy at the desired location on the skull, without puncturing the dura. The dura is later removed using fine forceps to minimize damage to the cortex. (e) A cannula guide is implanted on the skull through the craniotomy. (f) Metabond and dental cement are used to secure the cannula guide to the skull. (g) Vetbond and sutures are used to close the incision around the cannulation site. (h) An internal cannula guide connected to a pump is inserted through the cannula guide and is used to infuse virus into the target area in the brain. (i) The animal is allowed to rest in a recovery cage after surgical implantation. light path. Light flashes can be generated either by a lamp coupled to a fast shutter (e.g., Lambda DG-4 or Uniblitz shutter) or by directly modulating the intensity of light output using a waveform generator (lasers and LEDs; for optimal excitation wavelengths see Table 1 ).
For in vivo light delivery in freely moving animals, high power lasers (~10-15 mW output at the tip of a 100 µm fiber) and LEDs are most suitable. For superficial stimulation of cortical layers, commercially available small LEDs can also be directly mounted above the brain over a thinned skull area or cranial glass window 15, 24 . To target deep brain structures, we have found that thin optical fibers can be used to efficiently transmit sufficient powers of light to the target area 8, 49 . Optical fibers are versatile elements that can be fused to recording electrodes (creating an optrode 24 as described below for electrophysiological readout) and coupled to lasers and LEDs by FC/PC connectors. For mice, up to 300 µm fibers (bare fiber without plastic cladding) can be used without compromising animal movement, whereas we find that rats can tolerate up to 400 µm fibers. The length of the bare optical fiber can be customized based on the depth of the brain area by removing the precisely suitable length of plastic cladding. Mammalian brain tissue scatters light heavily, but ~10% of initial light power density remains at a distance from the fiber tip of ~500 µm 8, 49 . To avoid fiber breakage resulting from repeated insertion through the cannula guide system, a short fiber segment can be permanently implanted in the target region. During experiments, this short indwelling fiber segment can be coupled to a longer fiber connected to the laser by a custom fiber-to-fiber connector (Doric Lenses, Quebec, Canada). This strategy avoids fiber breakage, minimizes damage to brain tissue compared with implanted cannulas and reduces the likelihood of infection due to environmental exposure through the cannula. However, the fiber connector can lead to up to 50% loss of transmitted light, which may be overcome with more powerful laser diodes.
Choice of behavioral subjects: it is important to choose the appropriate species and genetic background according to the behavioral assay. For example, BALB/C animals are more suitable than C57BL6/J animals for anxiety and depression studies, whereas C57BL6/J are preferred over BALB/C for locomotor and cognitive studies 51 . When using transgenic mouse lines, it is often important to make sure that the mice are backcrossed (at least for six generations) 52 to the appropriate genetic background. Mechanical design considerations for behavioral equipments: during optogenetic behavioral experiments, each animal subject will have an optical fiber tethered to the skull throughout the experiment. Therefore, each subject should undergo sufficient habituation for the behavioral setup. Certain kinds of experimental apparatus containing obstacles such as doors, tunnels or closed compartments may need to be modified to allow free passage of the optical fiber. In some experiments, the acute insertion and removal of an optical fiber before and after the behavior test may be stressful for the experimental subject; therefore, previous handling will help alleviate this stress. A fiber commutator (Doric Lenses) may be used to relieve tension in the fiber and provide more rotational freedom for the experimental animals.
Summary.
We have provided a compact collection of our key technical insights and protocols for optogenetic targeting of deep brain structures in mammals, as well as our protocols for major , Sigma, cat. no. K4138). Alternatively, isoflurane may also be used. ! cautIon Ketamine is a controlled substance and should be handled according to relevant rules of REaGEnT SETup Virus injection setup Fill the syringe, the tubing and the glass needle or injection cannula with paraffin oil. Load the virus solution in the needle or injection cannula using the programmable microsyringe pump. D-10 cell maintenance medium Prepare 500 ml of D-10 medium by supplementing 500 ml of DMEM with 50 ml of fetal bovine serum, 5 ml of penicillin-streptomycin-L-glutamine mixture, 5 ml of sodium pyruvate and 5 ml of sodium bicarbonate. The final mixture can be stored at 4 °C for 1 month. Virus production medium Prepare serum-free virus production medium by supplementing 500 ml of UltraCULTURE with 5 ml of penicillin-streptomycin-L-glutamine mixture, 5 ml of sodium pyruvate and 5 ml of sodium bicarbonate. ) in 5 ml ethanol and aliquot into ten 0.5 ml aliquots (5 mg ml − 1 ) in 1.5 ml microcentrifuge tubes. Evaporate the solvent from aliquots by centrifuging it in a vacuum centrifuge until dry (~30 min, drying rate: medium, no heat). Each aliquot will contain 2.5 mg of RH 155 dye. Dried aliquots may be stored at 0 °C for up to 1 year. preparation of slice staining solution On the day of experiment, transfer 2.5 mg of RH 155 dye into 25 ml of ACSF to yield a final concentration of 0.1 mg ml − 1 . Minimize the exposure to light with aluminum foil wrapping and store at RT. Equilibrate the solution with 95% CO 2 /5% O 2 . agarose blocks for slicing Prepare 1% agarose solution by adding 1 g of agarose into 100 ml of distilled water. Heat the agarose/water mixture in a microwave until agarose has completely dissolved (~1 min at high heat). Cool to 50 °C and then pour the agarose solution into 10 cm petri dishes (~50 ml per petri dish). After the agarose has solidified, wrap the plates with parafilm to avoid evaporation and store at 4 °C for up to 6 months. On the day of experiment, cut the block large enough to support brain samples (1 cm × 0.5 cm × 0.5 cm). 12| Divide the filtered virus-containing supernatant among the six centrifuge tubes.
13| Pipette 2 ml of 20% sucrose solution to the bottom of the centrifuge tube.  crItIcal step It is important to pipette slowly so that the sucrose solution forms a discrete layer.
14|
Centrifuge in a Beckman SW-28 rotor for 2 h at 82,700g at 4 °C.
15|
Gently carry the centrifuge tubes back to the tissue culture hood and pour out the supernatant. There should be a tiny semi-transparent pellet at the bottom of each tube that resembles a soft contact lens. Dry the side of each tube with Kimwipe. ! cautIon Supernatant may contain trace virus. Apply bleach to the medium to decontaminate. 16| Add 100 µl of cold PBS to the first tube and resuspend the pellet by swirling and gentle pipetting.  crItIcal step Excessive pipetting will degrade the virus.
17|
Transfer the medium from the first centrifuge tube into the next tube to resuspend the second pellet. Repeat for the four additional tubes.
18|
Pipette the virus solution into an Eppendorf tube and spin the solution at 1,000g for 5 min to remove unsuspended virus debris. Centrifugation can be carried out at either room temperature or 4 °C.
19|
Aliquot the supernatant and store at − 80 °C for up to 1 year.  pause poInt The supernatant can be stored at − 80 °C for up to 1 year. stereotactic injection and cannula placement into the rodent brain (Fig. 2) 20| animal preparation. C57BL/6 mice (15-30 g) or Fisher rats (~200-300 g) should be housed and handled according to institutional and national guidelines.
21|
Ensure that all surgical tools are clean and sterile. Disinfect the area with 70% ethanol and sterilize all tools by autoclaving or immersion in a disinfectant.  crItIcal step Perform all the surgeries under aseptic conditions.
22|
Anesthetize rodents using 1.5% isoflurane (for surgeries longer than 1 h) or i.p. injection (90 mg kg − 1 ketamine and 5 mg kg − 1 xylazine for rats; 80 mg kg -1 and 15-20 mg kg − 1 , respectively, for mice).  crItIcal step Check for the absence of toe-pinch reflex. Dispose of excess anesthesia according to institutional regulations. ? troublesHootInG 23| Apply ophthalmic ointment to prevent eye drying.
24|
Use a heating pad to maintain the body temperature at 35 °C.
25|
Place the animal in a stereotactic frame. Fix the first ear (or head) bar and appose the animal's ear canal to the ear bar by applying moderate pressure; place the second ear bar in the opposite ear while gently holding the animal; insert the mouth holder between the jaws of the animal; and finally, attach the nose holder to the animal using low pressure.  crItIcal step Correct head position in the stereotactic frame allows tilt, but no lateral movement of the head.
26|
Shave and clean the head, wipe with 70% ethanol and betadine.
27|
Inject saline solution subcutaneously to prevent dehydration during surgery (30 ml kg − 1 of body weight: ~0.5 ml for adult mouse and ~5.0 ml for adult rat).
28|
Make a midline scalp incision of ~1 cm using scalpel. Gently pull the skin aside to expose the skull (Fig. 2a) . Clean the skull with cotton swabs immersed in hydrogen peroxide.  crItIcal step The thin membranes covering the skull will be disrupted immediately upon exposure to hydrogen peroxide and will appear as a layer of white foam. Stop the reaction with PBS immediately after the application of hydrogen peroxide by wiping with a cotton swab soaked in PBS and remove debris with a scalpel blade.
29|
After cleaning the skull with cotton swabs, identify the bregma (the point of intersection of the sagittal suture with the curve of best fit along the coronal suture) and the lambda (midpoint of the curve of best fit along the lambdoid suture) 53 ( Fig. 2b) .  crItIcal step Align the bregma and the lambda to the same dorsal-ventral (or z) coordinates by adjusting the height of the nose clamp on the stereotactic frame until the head is flat. Align the x and y tilt of the animal's head by measuring the x and y coordinates of the bregma and the lambda.
30|
Use a brain atlas to identify the coordinates for the target structure. 
31|
Move to the targeted area defined by the coordinates (Fig. 2c) . Slowly make a small craniotomy (slightly larger diameter than the cannula guide) using a drill mounted on the stereotactic frame (Fig. 2d) .  crItIcal step To minimize damage to the brain, do not drill through the dura and instead use fine forceps to remove the dura. This is crucial for cortical injections. ? troublesHootInG 32| Thaw the virus on ice. Lentivirus can be kept on ice for 6 h without significantly affecting the titer, whereas AAV can be stored at temperatures as warm as 4 °C for at least 1 month without the loss of significant titer.
33|
Place the cannula in the cannula holder on stereotactic frame and slowly lower the cannula guide into the brain. ? troublesHootInG 34| Dry the skull with cotton swabs. Apply a thin layer of C&B Metabond where the dental cement will be in contact with the skull, including around the cannula pedestal.
35|
Once the C&B Metabond hardens, release the cannula from the holder and withdraw the cannula holder without moving the cannula guide (Fig. 2e) . Secure the cannula pedestal with dental cement and ensure that at least two rounds of threads in the cannula pedestal are exposed (Fig. 2f) .
36|
Glue the skin back with Vetbond surgical adhesive (Fig. 2g) .
37| Perform virus injection during surgery (A) or after surgery (B). It may be necessary to titrate the virus (box 1).
(a) Virus injection during surgery (We describe here our protocol using the micropump from WPI and with special attention on the surgical procedure and cannula implantation for virus injection into rodent brain. Virus can also be delivered using glass capillaries to minimize tissue damage 54 .) (i) Inject 0.2-0.5 µl of virus into the brain using a 10 µl microsyringe and a thin 34 G metal needle.
(ii) Control the injection volume and flow rate (0.1 µl min − 1 ) with a high precision injection pump (Fig. 2h) . (iii) After injection leave the needle in place for 10 additional min to allow the virus to diffuse in the brain.
Withdraw the needle slowly afterwards. (iv) After completely withdrawing the needle check that it is not clogged by pumping out a small droplet (0.1 µl). (b) Virus injection after surgery (i) Carry out this procedure after the dental cement is dry, while the animal is still anesthetized.
(ii) Use an internal cannula fitted to the cannula guide's length (Fig. 2i) .
(iii) Connect the internal/injector cannula to the tubing filled with oil (which is connected to the microsyringe), load it with virus solution and place it into the cannula guide. (iv) Infuse the virus at a very low rate (0.1 µl min − 1 ) as described above. ? troublesHootInG 38| Give buprenorphine (0.03 mg kg − 1 ) subcutaneously following the surgical procedure to minimize pain/discomfort.
39|
Let the animal fully recover in a clean cage placed over a heating blanket (Fig. 2i) . Monitor the recovery of the animal every 10 min.
40| simultaneous optical stimulation and electrical recording in living mice with the optrode method
Prepare the optrode by firmly attaching an extracellular tungsten electrode (1 mΩ, ~125 µm) to an optical fiber (~200 µm) (TIMING 10 min).  crItIcal step The tip of the electrode must be deeper (>0.3mm) than the tip of the fiber to ensure illumination of the recorded neurons and prevent artifacts 24 .  crItIcal step Do not contact the tip of the electrode. (ii) Place animal in stereotactic frame (Step 25) so that the cannula is vertically aligned.
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42|
Use an electrode holder to mount the optrode (or optrodes for more than one location) on the stereotactic frame.
43|
Lower the optrode to the desired depth through the freshly made craniotomies or through the cannula.  crItIcal step Take all precautions not to damage the electrode tip. Avoid touching the skull or the cannula directly with the electrode tip; once the tip is safely inside the cannula it will not get damaged as it is lowered further.
44| Attach a ground wire to the scalp as a reference signal.
45|
Connect the optical fiber to a laser diode of desired wavelength and the electrode to an amplifier. For single unit recordings the recorded signal is band pass filtered between 300 Hz and 5 kHz. For field potentials, low-pass filter the signal at 300 Hz.
46|
Use an ADC board (e.g., Digidata) and control software (e.g., pClamp) to collect data and generate light pulses through the fiber.
? troublesHootInG
47|
If desired, sacrifice the animal immediately after recording. The brain may be extracted and sectioned to verify opsin gene expression and accurate placement of the optrode or acute slices can be prepared for electrophysiology or VSDI.
setting up optical stimulation for behavioral assays 48| preparation of onI fibers (Fig. 3) . Prepare the ONI fiber using cannula parts from PlasticsOne. These consist of a screwing cap for securing the fiber to the animal's head, a fiber guard from the internal cannula adapter and a bare fiber with length customized based on the depth of the target region. Prepare the screwing cap by drilling a ~2 mm diameter hole centrally on the top of a dust cap to allow the optical fiber to pass through (Fig. 3c,d ).
49|
Remove the metal tubing from the plastic pedestal of an internal cannula (Fig. 3e,f) .
50| Use a fiber stripping tool to remove ~40 mm of plastic coating from the bare end of an optical fiber (Fig. 3g) .
51|
Thread the fiber through the cap with the cap opening facing away from the FC connector on the fiber (Fig. 3h) . Thread the fiber through the plastic pedestal so that the snap-on part faces away from the FC connector on the fiber (Fig. 3i) .
52| Apply a very thin layer of glue to the interface of coated/uncoated fiber and slide the plastic pedestal onto the fiber so it is tight against the plastic coating on the fiber (Fig. 3j-l) . Allow the glue to dry for 10 min.  crItIcal step Do not apply excess glue. Too much glue will set slowly, prevent the cap from fitting over the internal cannula and also prevent the internal cannula from snapping onto the cannula guide.
53|
Insert the ONI fiber through a cannula guide (same dimensions as the ones implanted on the experimental animals) and ensure that the components snap tightly (Fig. 3m,n) . Use a diamond knife to cut the fiber so that it projects 0.5 mm from the tip of the cannula guide (Fig. 3o,p) . It is not necessary to polish the fiber end.  crItIcal step It is important to use a diamond knife so the fiber tip is flat to ensure consistent illumination. After cutting, check the fiber tip under a stereomicroscope.
54|
Connect the FC end of the fiber to the PC connector on the output port of the laser. Connect the laser control box to a waveform generator. 
55|
Program the waveform generator with the desired stimulation protocol (i.e., pulse frequency, duration and intensity).  crItIcal step Use a power meter to measure the light output at the end of the fiber before and after behavioral testing.
56|
In vivo stimulation for behavior. Insert the ONI fiber through the cannula guide on the animal's head and tighten the screw cap to secure the fiber.  crItIcal step Extra care should be taken during fiber insertion to prevent breakage.  crItIcal step For most behaviors, it is necessary to habituate the animals to the experimental setup by practicing fiber insertion/removal several times. The animals should be placed in the behavioral testing room for at least 3 h before behavioral testing.
? troublesHootInG 57| Begin behavioral testing. Stimulation can be applied by triggering the waveform generator.
58| Verify the cannula placement and opsin gene expression by post-behavioral histological analysis.
all-optical stimulation and activity imaging in slices using VsD 59| optics setup On an upright microscope, set up the stimulation light source (e.g., DG-4) to interfere with the epifluorescence port. The light source or a shutter needs to be in place to allow precisely timed flashes of stimulation light.
60|
Set up the VSD filters by placing the imaging filter cube carrying both the dichroic (reflect < 665 nm light to the tissue sample) and emission filter (710 nm bandpass).
61|
Connect the halogen lamp to the diascopic lamphouse port and use this light source for illumination of RH 155-stained slices. Place the illumination filter (710 nm) into a slot in the condenser. This filter isolates 710 nm light from the diascopic lamphouse for illumination of RH 155-stained slices. RH 155 is an absorbance dye; the filter placed in the condenser filters the light coming from the bright field light source below the tissue sample, and the amount of transmittance reflects the changes in membrane voltage.
62| staining in rH 155 dye Prepare acute brain sections from the brain region of interest 55 . While the slices are recovering in cutting solution with perfusion of CO 2 /O 2 , prepare fresh ACSF solution.  crItIcal step Make sure that the pH of the ACSF is between 7.3 and 7.4. Perfuse the ACSF with 95% CO 2 /5% O 2 for 10 min before using.
63|
Dilute one aliquot of RH 155 dye with 25 ml ACSF to prepare staining solution. The solution should appear dark blue in color.  crItIcal step It is important to minimize light exposure to the dye. Wrap aluminum foil around all dye containers and keep all the dye solutions in the dark.
64|
Equilibrate the staining solution in 95%O 2 /5%CO 2 at room temperature (25 °C) for 10 min.  crItIcal step Wrap foil around staining container and keep in dark.
65|
Quickly transfer the slices from the water bath to the staining solution and incubate the slices in the dark for three hours while bubbling with 95%O 2 /5%CO 2 .  crItIcal step Place slices flat and spaced evenly, completely immersed in solution. Minimize light exposure by wrapping containers in foil and staining in darkness. Consistent timing, dye concentration and staining area are crucial.
66| setting up the sample and optimizing the image Transfer the slices in the cell strainer from the staining solution to fresh, ACSF equilibrated with 95% O 2 /5% CO 2 to wash away excess dye. Incubate the slices in the fresh ACSF for 15 min. While the slices are recovering, perfuse the slice chamber on the microscope with equilibrated ACSF. The slices should be evenly stained dark blue.
67|
Transfer a single stained slice from the cell strainer into the slice chamber on the microscope stage. Continue to perfuse the chamber with 95% O 2 /5% CO 2 ACSF.
68|
Ensure slice stability by placing a slice anchor around the edges of the slice. Ensure Lycra strings from the slice anchor do not cover the region of interest. 69| Adjust the slice to place it in the center of the field of the view and adjust intensity of excitation light (from halogen light source) to enhance contrast while minimizing camera saturation.  crItIcal step Ensure 100% of the illumination light is directed to the camera. After positioning the slice, close the shutter for the halogen light source to minimize photobleaching. All imaging sessions should be carried out in the dark to minimize noise and photobleaching.
70| stimulation and image acquisition Bear in mind that perfusion of ACSF during image acquisition can introduce motion artifacts. The camera can be set to trigger the function generator and DG-4, if desired. It is also recommended to simultaneously record light-evoked field potentials and to validate the effectiveness of optical stimulation, slice health and proper configuration of the VSDI setup. Process images using MATLAB.
• tIMInG Steps 1-3 
Virus-mediated cell-specific expression of microbial opsin genes in neural tissues
Both lentiviral and AAV vectors carrying an appropriate cell-specific promoter and the opsin gene of interest can mediate robust expression in targeted cell types ( Fig. 4a-d ) 49 . Injection of 1 µl of high titer VSVg pseudotyped lentivirus (>10 9 pfu ml − 1 ) or AAV (>10 12 gc ml − 1 ) into the cortex or the hippocampus can result in transduction volumes >1 mm 3 . Prolonged expression of any membrane protein driven by strong ubiquitous promoters, such as CAG, can lead to toxicity in neurons. However, when the transgene is driven by a reliable and strong cell-specific promoter, expression can be very well-tolerated, stable and also specific, with < 10% of transduced cells belonging to non-targeted cell types as identified by immunostaining for the marker protein. Thus far, both the human Synapsin I and murine CaMKIIa promoters have been used in viral systems (lentivirus or AAV) to drive strong pan-neuronal or excitatory neuron-specific expression, respectively, in the mammalian brain in vivo. The glial fibrillary acidic protein (GFAP) promoter can also be used to drive astrocyte-specific expression from a lentiviral vector. Other promising cell-specific promoters include ppHcrt 8 , Sst 56 and CCK 57 (see table 2 for a list of previously reported cell-specific promoters). When using cell-specific Cre transgenic mice, 1 µl of doubly floxed inverted opsin (DIO) Cre-dependent AAV can be delivered to the target brain area to achieve virtually 100% cell-specific expression in the Cre-expressing cell population.
With both lentivirus and AAV, microbial opsin genes will express stably for at least 6 months after injection, and when tagged with a fluorescent protein marker, the transduced cells will exhibit strong membrane-localized fluorescence. Comparatively, ChR2 is better localized to the membrane than NpHR and VChR1, but it may still be difficult to identify the somata of ChR2-EYFP expressing cells in intact tissue. To improve the visualization and identification of expressing cells, the optogenetic protein and the fluorescent protein tag can be expressed as two separated proteins using IRES 58 or 2A 59, 60 bicistronic linkers. Expressing different rhodopsins as separate proteins also ensures that both will integrate into the plasma membrane in the correct orientation. For most reliable optical control of axon terminals (Fig. 4e) , it is important to achieve a high level of expression in the axonal membranes; therefore, although physiological effects can be seen earlier, for viral mediated expression, it is optimal to wait until 4 or more weeks after injection before conducting experiments.
electrophysiological validation of functional expression
Depending on targeted cell type, the maximal evoked firing frequency will vary (for pyramidal neurons in the neocotex, cells expressing ChR2 can be driven to fire spikes up to 30 Hz reliably, whereas other cell types such as fast-spiking interneurons will be able to fire at 100 Hz or more). Spiking properties in targeted cells depend on spike and illumination history as well as on membrane expression level and local illumination intensity; for any given cell type and circuit, a detailed characterization should be carried out to determine the efficacy of light evoked spike trains. To track and validate activity modulation, optrode recordings can be carried out in vivo (Fig. 4e) . Artifacts, although much smaller than for electrical stimulation, can be occasionally observed 61 ; when present, such artifacts are correlated with the onset and offset of the light pulse; amplitude depends on light power and can be reduced with proper grounding and use of electrodes with coating extending to the tip and staggered relative to the optical fiber by 300-500 µm, as is typically important in any case for proper illumination of the recorded area. Imaging optogenetically controlled signals using VsD
Voltage-sensitive dyes imaging of optically evoked activity in neural circuits expressing light-gated ion channels allows for fast, all-optical interrogation and quantification of the spatiotemporal dynamics of ex vivo circuits. In general, brain sections prepared from younger animals ( < 6 weeks) yield optimal signals; however, older animals may still be used but with reduced signal properties. Brain sections should be prepared with sufficient thickness to preserve network connections in the target circuit (e.g., ~300 µm for mice and ~400 µm for rats). Because of the inherently low signal of VSDI (~0.1% change in absorbance or fluorescence) and high levels of optical noise, averaging individual pixels over multiple trials is often necessary. Along with averaging these pixels over time, several pixels can also be averaged over space (with reference to anatomical landmarks) to increase the signal-to-noise ratio. Software provided by Scimedia or other fast camera producers (i.e., Redshirtimaging) can carry out these initial tasks. However, more advanced post-processing and quantitative analysis methods are often carried out in our laboratory using algorithms written in Matlab 47 , available upon request. Optical stimulation of brain sections from a Thy1ChR2-YFP transgenic mouse with blue (470 nm) light reveals quantitatively reproducible optical changes in the brain tissue (Fig. 4f) . The signal is typically strongest in the CA1 region, where ChR2 expression is highest. Signals are also seen in the entorhinal cortex, the subiculum and the dentate gyrus as a result of both direct activation of ChR2 and percolating circuit activity. 
